A Rare Cutaneous Complication of Insulin in a Patient With Type 2 Diabetes That Developed Foot Necrosis at the Injection Site: A Result of Inadequate Patient Education

Abstract

Cutaneous complications of insulin became rare due to the introduction of highly purified recombinant human insulin preparations. We reported a case of a 63-year-old Anatolian man with type 2 diabetes mellitus that developed foot necrosis at the injection sites after local administration of analog recombinant mixed insulin to dorsal aspect of the foot due to foot pain. This case is rare and very interesting. The education of patients who use insulin is crucial to prevent skin-related complications of insulin therapy. So education is a part of treatment for patient with diabetes.




J Endocrinol Metab. 2014;4(1-2):36-38
doi: http://dx.doi.org/10.14740/jem210w